TerminatedPhase 4ACTRN12613000805774

A randomised trial of propofol sedation versus desflurane anaesthesia, used to supplement spinal anaesthesia, on the quality of recovery following hip replacement surgery in adult patients


Sponsor

The University of Melbourne

Enrollment

200 participants

Start Date

Sep 2, 2013

Study Type

Interventional

Conditions

Summary

The study aims to assess whether two different anaesthetic techniques can affect the postoperative quality of recovery in patients undergoing total hip replacement surgery. The two techniques are considered as sedation or light general anaesthesia as they supplement a spinal anaesthetic - which is the primary anaesthetic technique for these patients. The quality of recovery is measured using a scale called the PQRS, which measures recovery in a number of different domains and compares recovery to the patients pre-surgery values.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria1

  • Adult patients undergoing hip replacement surgery under spinal anesthesia

Exclusion Criteria1

  • Patients, who are not fluent in English will be excluded, as they may be unable to answer the recovery questionnaire adequately. Patients where either general or regional anesthesia is contraindicated, will be excluded

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

For patients receiving propofol infusion, the dose will be adjusted according to sedation requirements by the anaesthetist (This may range fom 50-500 mg/hr via intravenous infusion). Patients will be

For patients receiving propofol infusion, the dose will be adjusted according to sedation requirements by the anaesthetist (This may range fom 50-500 mg/hr via intravenous infusion). Patients will be spontaneously ventilating, with supplemental oxygen administered via a clear Hudson mask at 6 L /min. Supplemental midazolam (1-5 mg intravenous) is permitted. A BIS target of > 65 will be set for depth of sedation. For patients receiving desflurane anesthesia they will receive intravenous induction of anesthesia with propofol (50-200 mg) followed by desflurane via inhalation. Ventilation will be via larangeal mask anesthesia and spontaneous ventilation unless the treating anaesthetist considers that endotracheal intubation and mechanical ventilation is required for the particular patient. The dose of desflurane will be adjusted according to the clinical requirement by the anaesthetist. A target BIS of 40-60 will be set for depth of anaesthesia.


Locations(1)

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613000805774


Related Trials